Correlation Between G1 Therapeutics and Annexon

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both G1 Therapeutics and Annexon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining G1 Therapeutics and Annexon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between G1 Therapeutics and Annexon, you can compare the effects of market volatilities on G1 Therapeutics and Annexon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in G1 Therapeutics with a short position of Annexon. Check out your portfolio center. Please also check ongoing floating volatility patterns of G1 Therapeutics and Annexon.

Diversification Opportunities for G1 Therapeutics and Annexon

-0.61
  Correlation Coefficient

Excellent diversification

The 3 months correlation between GTHX and Annexon is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding G1 Therapeutics and Annexon in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Annexon and G1 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on G1 Therapeutics are associated (or correlated) with Annexon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Annexon has no effect on the direction of G1 Therapeutics i.e., G1 Therapeutics and Annexon go up and down completely randomly.

Pair Corralation between G1 Therapeutics and Annexon

Given the investment horizon of 90 days G1 Therapeutics is expected to generate 1.22 times more return on investment than Annexon. However, G1 Therapeutics is 1.22 times more volatile than Annexon. It trades about 0.05 of its potential returns per unit of risk. Annexon is currently generating about 0.03 per unit of risk. If you would invest  546.00  in G1 Therapeutics on September 19, 2024 and sell it today you would earn a total of  169.00  from holding G1 Therapeutics or generate 30.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy87.1%
ValuesDaily Returns

G1 Therapeutics  vs.  Annexon

 Performance 
       Timeline  
G1 Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days G1 Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong technical indicators, G1 Therapeutics is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
Annexon 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Annexon has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

G1 Therapeutics and Annexon Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with G1 Therapeutics and Annexon

The main advantage of trading using opposite G1 Therapeutics and Annexon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if G1 Therapeutics position performs unexpectedly, Annexon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annexon will offset losses from the drop in Annexon's long position.
The idea behind G1 Therapeutics and Annexon pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios